The Pandemic Treaty: A Global Test of Leadership and Equity
What if the next pandemic isn’t just a health crisis but a mirror reflecting our collective failures? This is the question that lingers as the world grapples with the unfinished business of the international pandemic treaty. Personally, I think this isn’t just about drafting a document—it’s about whether global leaders have the courage to prioritize humanity over politics.
The recent joint letter from WHO Director-General Tedros Adhanom Ghebreyesus and Brazilian President Luiz Inácio Lula da Silva to the G7 is more than a diplomatic nudge; it’s a wake-up call. They’re urging leaders to finalize the treaty’s most contentious element: the Pathogen Access and Benefit-Sharing System (PABS). What makes this particularly fascinating is how it exposes the fault lines between rich and developing nations. The PABS system is essentially a promise—countries sharing dangerous pathogens must be assured that the vaccines and treatments developed will benefit their own populations. Sounds fair, right? Yet, here we are, three years into negotiations, and the richest nations are dragging their feet.
In my opinion, this isn’t just about technicalities; it’s about trust. Developing nations are being asked to share potentially life-threatening pathogens without guarantees that they’ll reap the rewards. If you take a step back and think about it, this is a modern-day colonial dynamic playing out in the realm of public health. What many people don’t realize is that this isn’t just a moral issue—it’s a practical one. A virus doesn’t respect borders. As Tedros and Lula aptly put it, ‘A virus left free to spread in one place will, in time, reach everyone.’
One thing that immediately stands out is the urgency. Scientists estimate a 25% chance of another pandemic in the next decade. Yet, we’re still haggling over details. The COVID-19 pandemic, which claimed an estimated 20 million lives, was a dress rehearsal for this moment. Humanity vowed to do better. But are we? The treaty, adopted in May 2025, is a historic step forward, but without PABS, it’s toothless.
From my perspective, the July negotiations are a make-or-break moment. Tedros and Lula are right to frame July 17 as a deadline, not just another milestone. But here’s the kicker: even if the treaty is finalized, will it be enough? Rapid advances in biotechnology are outpacing global biosafety measures, increasing the risk of accidental or deliberate pathogen spread. This raises a deeper question: Are we prepared for the pandemics of the future, or are we still stuck in the mindset of the past?
A detail that I find especially interesting is the role of the G7 in all this. Brazil, invited to the G7 summit in Évian, France, is positioning itself as a bridge between the Global South and the wealthiest nations. Lula’s presence isn’t just symbolic—it’s strategic. Brazil, a developing nation with a robust biotech sector, understands the stakes. What this really suggests is that the pandemic treaty isn’t just a health issue; it’s a geopolitical one.
If the G7 fails to act, the consequences could be dire. Not just in terms of lives lost, but in the erosion of global trust. Personally, I think this is a moment for leaders to prove that multilateralism isn’t dead—that it can work, even in the face of deep divisions.
In the end, the pandemic treaty is more than a document. It’s a test of our collective humanity. Will we rise to the occasion, or will we let politics and greed dictate our response to the next crisis? As Tedros and Lula remind us, the world must finish what it started. The question is: do we have the will to do it?
